Chemomab Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMMB and other ETFs, options, and stocks.

About CMMB

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis.

CEO

Dale R. Pfost

CEODale R. Pfost

Employees

—

Employees—

Headquarters

Tel Aviv, Tel Aviv

HeadquartersTel Aviv, Tel Aviv

Founded

2011

Founded2011

Employees

—

Employees—

CMMB Key Statistics

Market cap

26.17M

Market cap26.17M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

43.11K

Average volume43.11K

High today

—

High today—

Low today

—

Low today—

Open price

$2.30

Open price$2.30

Volume

0.00

Volume0.00

52 Week high

$5.56

52 Week high$5.56

52 Week low

$1.75

52 Week low$1.75

CMMB Earnings

-$0.70

-$0.47

-$0.23

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 8, Pre-Market

ActualExpected Mar 8, Pre-Market

Chemomab Therapeutics

Why Robinhood?

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. Show more

CMMB Key Statistics

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis.